Cas:53251-94-8 Pinaverium Bromide manufacturer & supplier

Chemical Name:Pinaverium Bromide

CAS.NO:53251-94-8

Synonyms:4-(6-Bromoveratryl)-4-[2-[2-(6,6-dimethyl-2-norpinyl)ethoxy]ethyl]morpholinium Bromide;LAT 1717;Dicetel;EINECS 258-450-0;Pinaverium bromide;UNII-7SCF54H12J;Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, bromide (1:1);4-(2-Bromo-4,5-dimethoxybenzyl)-4-{2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl}morpholin-4-ium bromide;4-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholinium Bromide

Molecular Formula:C₂₆H₄₁Br₂NO₄

Molecular Weight:591.416

HS Code:

Physical and Chemical Properties:

Melting point:159-164ºC

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:36.92000

Exact Mass:589.140198

LogP:2.25510

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(6-Bromoveratryl)-4-[2-[2-(6,6-dimethyl-2-norpinyl)ethoxy]ethyl]morpholinium Bromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholinium Bromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dicetel Use and application,LAT 1717 technical grade,usp/ep/jp grade.

Related News: For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” Pinaverium Bromide manufacturer A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. Pinaverium Bromide supplier A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. Pinaverium Bromide vendor Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. Pinaverium Bromide factory Of the nearly 4,000 Black women and more than 25,000 white women included in the study, there was no statistically significant difference in breast cancer-related genetic mutations. They were found in 5.65% of Black women and nearly 5.1% of white women.